Answers are grounded in this paper and cite their sources.
"Failure of “Optimal” Four-Drug Short-Course Tuberculosis Chemotherapy in a Compliant Patient with Human Immunodeficiency Virus." American Review of Respiratory Disease, 136(6), pp. 1475–1478
No takes yet. Share an insight, caveat, or question.
Sunderam et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: